Literature DB >> 7081456

Flow dependence of norepinephrine extraction by isolated perfused rat lungs.

R A Roth.   

Abstract

Disposition of perfused norepinephrine (NE) was studied in isolated rat lungs at several perfusate flows, including that occurring in vivo. Lungs were ventilated with 95% O2-5% CO2 and perfused at 37 degrees C with recirculating medium initially containing 90 nM [14C]NE. In agreement with previous studies the fraction of NE removed in a single pass through the pulmonary vasculature was 0.30 +/- 0.03 by lungs perfused at low flow (10 ml/min; 7.2 ml.min-1.g lung-1). This extraction ratio decreased with increasing flow, so that in lungs perfused at 45 ml/min (31.8 ml.min-1.g lung-1) the extraction ratio was 0.09 +/- 0.01. The concentration of NE metabolites in the perfusate reservoir increased with time of perfusion. The rate of appearance of deaminated and O-methylated metabolites in the recirculating perfusion medium was not markedly influenced by flow. NE that accumulated in lung was metabolized before reentry into the perfusion medium. These results indicate that extraction of NE by rat lung is markedly dependent on flow and suggest that removal of NE by lung is not highly efficient at normal organ perfusion rates.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081456     DOI: 10.1152/ajpheart.1982.242.5.H844

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Pulmonary distribution of alfentanil and sufentanil studied with system dynamics analysis.

Authors:  F Boer; A Hoeft; M Scholz; J G Bovill; A G Burm; A Hak
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

2.  Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stress.

Authors:  J Hilsted; N J Christensen; S Madsbad
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

3.  Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).

Authors:  Yinuo Pang; Masahiro Sakagami; Peter R Byron
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.